โšกToday

GSK Wins FDA Approval for Hepatitis B Drug

STAT 21 October 2026 1 min read

โฎ BeforeFewer hepatitis B patients could reach a functional cure with earlier methods.
โœ… NowWith FDA approval, far more patients can be considered for a functional cure.

In short

  • The US Food and Drug Administration has approved GSK's hepatitis B drug.
  • The source says the drug extends functional cures to far more patients than previous methods.
  • Functional cure means the virus is controlled after treatment, without continuing treatment.

Why the Good News Desk likes this one

The approval gives doctors a new option for treating hepatitis B. The source says it reaches far more patients than previous methods. The source does not give trial details or patient numbers, so the scale of the change is not yet clear.

Advertisement

From STAT

GSK has won FDA approval for its hepatitis B drug, which extended functional cures to far more patients than previous methods.

Read the full story at STAT Opens the publisher's site in a new tab.

Ask this story

Answers come only from the material behind this story, with a link to the source.

Next in today's ten

Advertisement
AdMobile anchor